Schwerdtner Nora-Lynn, Kipp Frank
Institut für Infektionsmedizin und Krankenhaushygiene, Abteilung Krankenhaushygiene, Bereich Public Health, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Deutschland.
Urologe A. 2020 Nov;59(11):1407-1416. doi: 10.1007/s00120-020-01360-0.
Infections caused by multidrug-resistant pathogens and their inpatient (nosocomial) and outpatient spread, pose increasing challenges to our healthcare system. Control strategies are derived from vertical (individual, pathogen-specific) and horizontal (general, pathogen-unspecific) preventive measures. The discussion of a competing "either or" has not proven to be effective in the past. In addition, the problem of multidrug-resistant pathogens cannot be solved solely in inpatient health care: the goals are a seamless communication and transparent cooperation between all actors in the healthcare system. Nowadays, modern molecular methods for pathogen typing are available, with the help of which transmission pathways can be clarified and hospital hygiene measures can be efficiently controlled. These procedures will be used increasingly more in the future to combat the problem of multidrug resistance across interfaces within regional network structures.
多重耐药病原体引起的感染及其在住院患者（医院内）和门诊患者中的传播，给我们的医疗系统带来了越来越大的挑战。控制策略源自纵向（针对个体、特定病原体）和横向（通用、非特定病原体）预防措施。过去，关于相互竞争的“非此即彼”的讨论已证明无效。此外，多重耐药病原体的问题不能仅在住院医疗中解决：目标是医疗系统中所有参与者之间实现无缝沟通和透明合作。如今，有了现代病原体分型分子方法，借助这些方法可以明确传播途径并有效控制医院卫生措施。未来，这些程序将越来越多地用于应对区域网络结构内跨界面的多重耐药问题。
